SEARL in a notice informed that it has concluded an exclusive licensing & supply agreement with Livzon Mapharm Inc for the “recombinant novel coronavirus vaccine(V-01)’ which also covers manufacturing transition of (V-01) in Pakistan.
More like this
SAZEW Three-Wheeler sales declined by 31.6% in Feb
The Sazgar Engineering Works Limited (PSX:SAZEW) announced the production & sales data for the month of February, 2024.Three-Wheelers:
The...
MARI hits success with second Ghazij Well in Sindh lease
Mari Petroleum Company Limited (PSX: MARI) has successfully drilled and tested the second appraisal well in the...
Avanceon has secured a Multi-Million Dollar contract in Middle...
Avanceon Ltd (PSX: AVN) in a notification to the PSX, announced that Avanceon Automation & Control W.L.L...